Amgen soars on weight loss drug progress, Novo Nordisk, Eli Lilly slide
Amgen's stock rose more than 12% on Friday after the drugmaker teased positive initial data on its experimental weight loss injection. That fueled investor concerns about new competition in the rapidly...